BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong RS. Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications. Human Immunology 2015;76:781-8. [DOI: 10.1016/j.humimm.2015.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Ma D, Wu Z, Yang B, Li R, Zhao X, Yang H, Zhang L. Clinical application of mesenchymal stem cells in rheumatic diseases. Stem Cell Res Ther 2021;12:567. [PMID: 34753496 DOI: 10.1186/s13287-021-02635-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Wong RSY. Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis. Adv Pharmacol Sci 2019;2019:5324170. [PMID: 30838041 DOI: 10.1155/2019/5324170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 Abdolmohammadi K, Pakdel FD, Aghaei H, Assadiasl S, Fatahi Y, Rouzbahani NH, Rezaiemanesh A, Soleimani M, Tayebi L, Nicknam MH. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach. Biomed Pharmacother. 2019;109:1196-1205. [PMID: 30551369 DOI: 10.1016/j.biopha.2018.10.137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
4 Rademacher J, Poddubnyy D. Emerging drugs for the treatment of axial spondyloarthritis. Expert Opinion on Emerging Drugs 2018;23:83-96. [DOI: 10.1080/14728214.2018.1445719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Rios Rodriguez V, Llop M, Poddubnyy D. Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? Immunotherapy 2017;9:899-911. [PMID: 29338611 DOI: 10.2217/imt-2017-0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]